![](https://capedge.com/proxy/8-K/0001364099-08-000178/q308earningsprfinallinkex1x1.jpg)
FOR IMMEDIATE RELEASE
INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2008 RESULTS
CRANBURY, New Jersey – (November 3, 2008) –Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading specialty phosphates producer in North America, today announced its financial results for the third quarter 2008.
Third Quarter Results
Net sales for the third quarter 2008 were $291.8 million, an increase of $145.4 million, or99%, as compared to $146.4 million for the same period in 2007. Selling price increases hada positive impact on revenue of 113% or $164.9 million that occurred across all productlines. Volume and mix impacts on revenue had a negative impact of 13.3% or $19.5 millionthat occurred primarily in STPP & Other Products due to reduced demand for our granulartriple superphosphate (GTSP) fertilizer co-product in oversupplied fertilizer markets andlimited reformulation in detergents using sodium tripolyphosphate (STPP). Demand wasfavorable for Specialty Salts & Specialty Acids and stable for Purified Phosphoric Acid inboth the United States and Mexico.
Operating income for the third quarter 2008 was $112.9 million, an increase of $94.9 million,or 527%, compared to $18.0 million for the comparable period in 2007. There were nounusual items to report for either period.
Depreciation and amortization for the third quarter 2008, excluding deferred financingamortization expense, was $13.2 million, an increase of $1.5 million compared to $11.7million for the third quarter of 2007.
Net interest expense for the third quarter 2008, including deferred financing amortizationexpense, was $8.9 million, a decrease of $0.4 million, compared to $9.3 million for thecomparable period in 2007.
Tax expense for the third quarter 2008 was $25.4 million, an increase of $22.2 millioncompared to $3.2 million for the comparable period in 2007.
Net income for the third quarter 2008 was $79.7 million, an improvement of $74.1 millioncompared to $5.6 million for the same period in 2007.
Diluted earnings per share for the third quarter 2008 were $3.64 compared to $0.26 for thethird quarter of 2007.
As of September 30, 2008, Innophos had $123.1 million of cash and cash equivalents. Netdebt at the end of the third quarter 2008 was $259.9 million, a decrease of $81.1 million from$341.0 million at June 30, 2008. There were no borrowings under the Company’s revolvingcredit line at September 30, 2008. Capital expenditures for the third quarter 2008 were $4.0million versus $11.0 million in the same quarter of 2007 when the company was investing inthe cogeneration project (completed in March 2008) at its Coatzacoalcos facility.
Randy Gress, CEO of Innophos commented on the results: “We are extremely pleased that our operating and net income, at $112.9 million and $79.7 million, respectively, set new company records for the third straight quarter. We are continuing to successfully grow our specialty salts and specialty acids product line. We are anticipating and responding to the rapid changes in fertilizer and raw material markets. Despite this dynamic change, our core specialty phosphate business has continued to improve, and we have continued to maintain our focus and provide value to our customers through a high level of customer service, reliable product supply and quality, and continuous improvement of the efficiency and the reliability of our supply chain.”
Segment Results 3Q 2008 Versus 3Q 2007
United States
U.S. year on year quarterly net sales increased 77% due to higher prices across all productlines. Volumes were favorable in Specialty Salts and Specialty Acids. Phosphoric acidvolumes declined due to a hurricane-related outage affecting the Geismar, LA plant and theneed to rebuild inventories depleted during our second quarter maintenance outage at thisfacility.
Operating income increased by $41.1 million from $4.3 million in the third quarter of 2007to $45.4 million in the third quarter of 2008. This improvement was driven by higher sellingprices and effects of favorable volume and mix impacts which exceeded higher raw material,energy, freight and manufacturing fixed costs.
Mexico
Net sales increased 136% versus the comparable quarter of 2007 due to significantly higherprices across all product lines which exceeded lower volume and mix effects on revenue.STPP and Other Products accounted for all of the volume and mix declines primarily due toreduced demand for our GTSP fertilizer co-product in oversupplied fertilizer markets andlimited reformulation in detergents using STPP.
Operating income increased by $49.1 million, from $13.3 million in the third quarter of 2007to $62.4 million in the third quarter of 2008, driven by higher selling prices which exceededthe effects of lower volume and mix impacts and higher raw material, energy, freight andmanufacturing fixed costs.
2
Canada
Net sales increased 69% versus the same quarter in 2007 due to higher selling prices acrossall product lines which exceeded lower volume and mix effects on revenue across all productlines.
Operating income increased by $4.7 million from $0.4 million in 2007 to $5.1 million in2008 due to higher selling prices which exceeded the effects of lower volume and miximpacts and higher raw material, energy, and freight costs.
Recent Trends and Outlook
Market prices of phosphate rock, sulfur and sulfuric acid, the primary raw materials used in the production of specialty phosphates, have increased substantially over the last several quarters, although the market price of sulfur began to decrease rapidly in the fourth quarter of 2008. Innophos purchases phosphate rock, sulfur, and sulfuric acid directly and has other long term raw material supply contracts whose pricing is determined in part by phosphate rock and sulfur market prices. If current raw material market price levels for phosphate rock and sulfur are sustained throughout 2008 into 2009, Innophos currently estimates that its annual raw material costs will increase on an annualized basis by an amount equivalent to approximately 55% to 65% of 2007 annual sales, or by approximately $320 to $375 million, by the third quarter of 2009 as compared to Innophos’ year-end 2007 cost structure. Approximately 35% of this dollar cost increase, or approximately $115 to $135 million, is expected to occur during 2008, with the balance expected to occur in the first and second quarters of 2009.
Historically, Innophos has successfully recovered raw material, energy and other cost increases through price increases. In addition to offsetting raw material cost increases, management’s current pricing strategy targets pricing Innophos products at full value. During the fourth quarter of 2007, the Company implemented price increases in all its product lines, most of which became effective January 1, 2008. Innophos also implemented broad price increases in February, April, June and August 2008, and recently announced additional price increases across most products in the U.S. and Canada effective October 15, 2008. Due to oversupply and reduced demand conditions in phosphate fertilizer markets, Innophos expects the price received for its GTSP fertilizer co-product to decrease by over 45% from its peak third quarter 2008 levels. Innophos expects its price increases, net of anticipated GTSP price decreases, will result in a revenue increase of 95% to 105% of 2007 annual sales, or approximately $550 to $605 million, on an annualized basis by year-end 2008.
While Innophos cannot guarantee that its pricing actions will succeed, to date marketplace acceptance rates for price increases have been high. Finally, as Innophos raises prices, it is possible that demand for the Company’s products may decline to the extent its customers reformulate their products or otherwise reduce purchases.
3
In the first three quarters of 2008, Innophos experienced negative volume impacts on revenues for STPP and Other Products, which primarily affected the Mexico segment. The underlying causes for this decline are reduced fertilizer demand and oversupply impacting the sales of GTSP, limited reformulation in detergents using STPP, and an increase of competition from China in South America. In addition, Innophos expects to ship minimal amounts of GTSP fertilizer in the fourth quarter due to rapidly decreasing fertilizer market demand and pricing levels disrupting Latin American fertilizer markets. Management anticipates this will result in a shipment volume decline of approximately 30% on a pure tonnage basis for STPP and Other Products for the full year 2008 versus full year 2007. However, Innophos sees continued strong demand in its other product lines as it realizes growth for Specialty Salts & Specialty Acids and stable demand for Purified Phosphoric Acid in both the United States and Mexico.
During 2008 price increases have been achieved ahead of realized cost increases by a material amount. Management currently estimates that the favorable impact of net selling price increases exceeding raw material cost increases, net of the anticipated impact from lower sales volumes in STPP and Other Products, will result in at least a $65 million year over year improvement in operating income during the fourth quarter of 2008. Management believes the buffering provided by the Company’s long term raw material contracts will continue in 2009, albeit at a lesser rate than experienced in 2008, and that the trend of net selling price increases exceeding net raw material cost increases by a material amount relative to fourth quarter 2007 levels will continue through 2009.
This news release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities of Innophos Holdings, Inc., nor shall there be any offer, solicitation or sale of securities in any state in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that state.
About Innophos Holdings, Inc.
Innophos Holdings, Inc. (www.innophos.com), the holding company for a leading North American manufacturer of specialty phosphates, serves a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos' market-leading positions derive from its experience and dedication to customer service and innovation. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico). ’IPHS-G’
SOURCE Innophos Holdings, Inc.
###
4
Financial Tables Follow | |
Innophos Holdings, Inc. | Breakstone Group |
Investor Relations: (609) 366-1299 | Maura Gedid / Barbara Cano |
investor.relations@innophos.com | 646-452-2335 / 2334 |
Conference Call Details
The conference call is scheduled for Tuesday, November 4, 2008 at 10:00 a.m. ET and can be accessed by dialing 888-713-4215 (U.S.) or 617-213-4867 (international) and entering passcode 73675859. Please dial in approximately 15 minutes ahead of the start time to ensure timely entry to the call. A replay will be available between 12:00 pm ET on November 4 and 11:59 pm ET on November 18, 2008. The replay is accessible by dialing 888-286-8010 (U.S.) or 617-801-6888 (international) and entering passcode 10832518.
Safe Harbor for Forward-Looking and Cautionary Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos’ products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon third-party suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.
5
Summary Profit & Loss Statement – Third Quarter
INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES Condensed Consolidated Statement of Operations (Unaudited) (Dollars in thousands, except per share amounts or share amounts)
Three months ended | Three months ended | |||||
September 30, | September 30, | |||||
2008 | 2007 | |||||
Net sales | $ | 291,772 | $ | 146,451 | ||
Cost of goods sold | 165,189 | 116,714 | ||||
Gross profit | 126,583 | 29,737 | ||||
Operating expenses: | ||||||
Selling, general and administrative | 13,152 | 11,284 | ||||
Research & development expenses | 526 | 479 | ||||
Total operating expenses | 13,678 | 11,763 | ||||
Operating income | 112,905 | 17,974 | ||||
Interest expense, net | 8,886 | 9,256 | ||||
Foreign exchange (gain) loss | (869 | ) | 41 | |||
Other income, net | (152 | ) | (158 | ) | ||
Income before income taxes | 105,040 | 8,835 | ||||
Provision for income taxes | 25,388 | 3,204 | ||||
Net income | $ | 79,652 | $ | 5,631 | ||
Diluted earnings per share | $ | 3.64 | $ | 0.26 | ||
Diluted weighted average common shares outstanding | 21,857,587 | 21,370,809 | ||||
Dividends paid per share of common stock | $ | 0.17 | $ | 0.17 | ||
Dividends declared per share of common stock | $ | - | $ | 0.17 |
6
Segment Reporting – Third Quarter
The company reports its operations in three segments—United States, Mexico and Canada, each of which sells the entire portfolio of products. The primary performance indicators for the chief operating decision maker are sales and operating income, with sales on a ship-from basis. The following table sets forth the historical results of these indicators by segment:
Three months ended | Three months ended | |||||||
September 30, | September 30, | |||||||
2008 | 2007 | Net Sales % Change | ||||||
Segment Net Sales | ||||||||
United States | $ | 146,154 | $ | 82,768 | 76.6 | % | ||
Mexico | 133,732 | 56,659 | 136.0 | % | ||||
Canada | 11,886 | 7,024 | 69.2 | % | ||||
Total | $ | 291,772 | $ | 146,451 | 99.2 | % | ||
Segment Operating Income | ||||||||
United States | $ | 45,400 | $ | 4,302 | ||||
Mexico | 62,357 | 13,318 | ||||||
Canada | 5,148 | 354 | ||||||
Total | $ | 112,905 | $ | 17,974 | ||||
Segment Operating Income % of net sales | ||||||||
United States | 31.1 | % | 5.2 | % | ||||
Mexico | 46.6 | % | 23.5 | % | ||||
Canada | 43.3 | % | 5.0 | % |
Price / Volume – Third Quarter
The following table illustrates for the three months ended September 30, 2008 the percentage changes in net sales by reportable segment compared with the same period of the prior year, including the effect of price and volume/mix changes upon revenue:
Price | Volume/Mix | Total | ||||
United States | 73.4 | % | 3.2 | % | 76.6 | % |
Canada | 88.4 | % | (19.2 | %) | 69.2 | % |
Mexico | 173.0 | % | (37.0 | %) | 136.0 | % |
The following table illustrates for the three months ended September 30, 2008 the percentage changes in net sales by major product lines compared with the same period of the prior year, including the effect of price and volume/mix changes upon revenue:
Price | Volume/Mix | Total | ||||
Purified Phosphoric Acid | 174.7 | % | (20.6 | %) | 154.1 | % |
Specialty Salts and Specialty Acids | 68.0 | % | 15.4 | % | 83.4 | % |
STPP & Other Products | 146.3 | % | (62.1 | %) | 84.2 | % |
7
Summary Cash Flow Statement | ||||||
INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES | ||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) | ||||||
(Dollars in thousands) | ||||||
Nine months ended | Nine months ended | |||||
September 30, | September 30, | |||||
2008 | 2007 | |||||
Cash flows from operating activities | ||||||
Net income (loss) | $ | 148,195 | $ | (1,605 | ) | |
Adjustments to reconcile net income (loss) to net cash provided | ||||||
from operating activities: | ||||||
Depreciation and amortization | 40,371 | 34,477 | ||||
�� Amortization of deferred financing charges | 2,046 | 3,910 | ||||
Deferred income tax benefit | (879 | ) | (1,517 | ) | ||
Deferred profit sharing | 410 | 488 | ||||
Share-based compensation | 2,340 | 694 | ||||
Changes in assets and liabilities: | ||||||
Increase in accounts receivable | (44,019 | ) | (3,244 | ) | ||
Increase in inventories | (52,411 | ) | (8,752 | ) | ||
Increase in other current assets | (99 | ) | (4,567 | ) | ||
Increase in accounts payable | 4,748 | 8,417 | ||||
Increase in other current liabilities | 32,398 | 1,128 | ||||
Changes in other long-term assets and liabilities | (1,697 | ) | 958 | |||
Net cash provided from operating activities | 131,403 | 30,387 | ||||
Cash flows from investing activities: | ||||||
Capital expenditures | (13,238 | ) | (23,012 | ) | ||
Purchase of assets | - | (2,120 | ) | |||
Net cash used for investing activities | (13,238 | ) | (25,132 | ) | ||
Cash flows from financing activities: | ||||||
Proceeds from exercise of stock options | 392 | 896 | ||||
Proceeds from issuance of senior unsecured notes | - | 66,000 | ||||
Principal repayment of floating rate senior notes | - | (60,800 | ) | |||
Principal payments of term-loan | (1,500 | ) | (16,500 | ) | ||
Deferred financing costs | - | (1,815 | ) | |||
Excess tax benefits from exercise of stock options | 1,062 | - | ||||
Dividends paid | (10,664 | ) | (9,352 | ) | ||
Net cash used for financing activities | (10,710 | ) | (21,571 | ) | ||
Net change in cash | 107,455 | (16,316 | ) | |||
Cash and cash equivalents at beginning of period | 15,661 | 31,760 | ||||
Cash and cash equivalents at end of period | $ | 123,116 | $ | 15,444 |
8
Summary Balance Sheets | ||||
INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES | ||||
Condensed Consolidated Balance Sheets (Unaudited) | ||||
(Dollars in thousands) | ||||
September 30, | December 31, | |||
2008 | 2007 | |||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 123,116 | $ | 15,661 |
Accounts receivable - trade | 104,098 | 60,079 | ||
Inventories | 131,139 | 78,728 | ||
Other current assets | 18,483 | 18,384 | ||
Total current assets | 376,836 | 172,852 | ||
Property, plant and equipment, net | 237,764 | 260,563 | ||
Goodwill | 47,268 | 47,268 | ||
Intangibles and other assets, net | 57,498 | 62,016 | ||
Total assets | $ | 719,366 | $ | 542,699 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Current portion of long-term debt | $ | 55,004 | $ | 1,328 |
Accounts payable, trade and other | 41,192 | 36,444 | ||
Other current liabilities | 74,228 | 45,380 | ||
Total current liabilities | 170,424 | 83,152 | ||
Long-term debt | 327,996 | 383,172 | ||
Other long-term liabilities | 31,198 | 31,671 | ||
Total liabilities | 529,618 | 497,995 | ||
Total stockholders' equity | 189,748 | 44,704 | ||
Total liabilities and stockholders' equity | $ | 719,366 | $ | 542,699 |
Additional Information
Net debt is a supplemental financial measure that is not required by, or presented in accordance with, USGAAP. The Company believes net debt is helpful in analyzing leverage and as a performance measure for purposes of presentation in this release. The Company defines net debt as total debt less cash and cash equivalents.
9